AmSurg CEO Christopher Holden Expresses Optimism About Future of Company, Surgery Center Industry

Christopher Holden, CEO of AmSurg, discusses the current state of his company and the future of AmSurg and the ambulatory surgery center industry in a Q&A published in The Tennessean.

Advertisement

 

Mr. Holden speaks to issues including the company’s top volume procedures, trends driving future growth, impact of removal of the copay for screening rates for colonoscopies and the company’s approach to acquisitions.

Read the Q&A from The Tennessean with Christopher Holden.

 

Read more about AmSurg:

 

AmSurg Reports 11% Increase in Revenues, 2% Increase in Average Revenue Per Procedure

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

  • Atlanta-based United Digestive is planning an ASC in Watkinsville, Ga., focusing on organic growth to expand its network. The newly-constructed,…

  • At least 25 ASCs have closed over the past five years, a pattern of attrition driven by financial strain, staffing…

  • As the ASC industry continues to grow alongside new waves of surgical innovation, patient preferences and shifts to value-based care,…

Advertisement

Comments are closed.